Print Page | Sign In | Join
InSitu Biologics
Photo Not Available
Last updated: 4/3/2019
InSitu Biologics
Core Member
Professional Information
InSitu Biologics
President & CEO
1173 Jardin Drive
34104  United States
 [ Map ]
651 338-4801 (Phone)
Visit Website »
  A. Executive Management (CEO, Chairman, President)
Personal Information
Additional Information
  InSitu Biologics is an emerging biotech company focusing on development of AnestaGel™, a long-lasting and long-acting non-opiate painkiller. The sustained release drug AnestaGel is expected to be used in post-operative surgical procedures. AnestaGel may be a solution in relieving pain for broken bones, cosmetic surgery, hip/knee replacements, hernia, and more.
  Ramsey, MN
  Woodbury, MN
  Download File (pdf)
  Biotech/Medical Device/Pharma
  Biotechnology / Pharmaceutical
  Private - For Profit
About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.


Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.


NEW regional sponsorship opportunities available.